AzTrials
AzTrials

WeaknessPhase 3FAMENCT00666744

A Randomised Controlled Trial of Family Mediated Exercises (FAME) Following Stroke

A Phase 3 study testing Family Mediated Exercise Therapy in people with Weakness and Balance, run by University of Dublin, Trinity College at 2 sites in Ireland.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of the study is to evaluate the functional recovery in two groups of primary stroke patients presenting with moderate/severe disability over a six month period through the implementation of a randomised controlled trial. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Weakness, Balance
What is being tested?
Family Mediated Exercise Therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
40 participants
Where
2 sitesIreland
Study dates
Apr 2008to Mar 2009
Phase
Phase 3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • diagnosis of first unilateral stroke
  • Patients who score between 3.2 and 5.2 on the Orpington Prognostic Scale
  • Patients participating in a physiotherapy programme
  • Patients willing to give informed written consent
  • Patients with family willing to participate in their assigned physiotherapy intervention programme

Who cannot join

  • hemiplegia of a non-vascular origin
  • discharged from hospital less than two weeks following stroke
  • pre-existing neurological disorder
  • any lower limb orthopaedic condition that may limit exercise capacity
  • aphasia
  • cognitive impairment
  • not willing to give written consent

Trial locations and contacts

2 sites in 1 country.

Emma K Stokes, PhD contact

00 353 1 896 2127

estokes@tcd.ie

Rose Galvin, BSc contact

00 353 1 896 3613

rgalvin@tcd.ie

Ireland2 sites, 2 recruiting
  • Beaumont Hospital

    Dublin

    Julie Shanahan, BSc, 00 353 1 809 2535, julieshanahan@beaumont.ie

    Julie Shanahan, BSc

    Recruiting
  • MaterMisercordiae University Hospital

    Dublin

    Orla Friel, BSc, 00 353 1 8034273, physiorehab@mater.ie

    Orla Friel, BSc

    Recruiting

Other trials in Ireland

About this study

The aim of the study is to evaluate the functional recovery in two groups of primary stroke patients presenting with moderate/severe disability over a six month period through the implementation of a randomised controlled trial. The first group or the experimental group will receive routine therapy and additional lower limb exercise therapy in the form of family assisted exercises. The second group or the control group will receive routine therapy with no additional formal input from their family members. A secondary aim of the project is to evaluate the impact of the FAME programme on the person with stroke and the individual (s) assisting in the delivery of exercises.

Read the detailed description

Participants with primary stroke eligible for inclusion to the study at 2 weeks post stroke will be randomised into either a 'control' group that will receive routine therapy or an 'experimental' group that will receive routine therapy AND additional 'family mediated exercise therapy.

Training will be provided to the nominated family member (s)/friends of participants in the 'intervention' group on a weekly basis by the research physiotherapist (R1). Family members/friends will be requested to keep an exercise diary on a daily basis to document completion of exercises. The trial will continue for eight weeks with an expectation that at least 1200 additional minutes of FAME therapy will be delivered over this time period. Each FAME session is expected to last 35-40 minutes.

Exercises will include repetitive sit to stand exercises with an emphasis on improving symmetry, weight bearing exercises during standing, bridging, straight leg raises, quadriceps strengthening exercises, active/active assisted range of movement exercises for the lower limb and walking. Outcome will be assessed by a blinded outcome assessor (R2) on entry to the study, at eight weeks (post-intervention) and again three months post-intervention (follow-up)

In addition, a semi-structured interview will be carried out with a random sample of the participants and their family member (s)/friends to gain a more qualitative insight into the impact of the programme on those involved. This interview will be completed by a person unknown to the participant. (R3)

Conditions
Weakness, Balance
Being tested
Family Mediated Exercise Therapy
Keywords
exercise, frequency, duration
Medical subject headings
Asthenia, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Family Mediated Exercise TherapyOther

    35 minutes of lower limb exercises to be completed by the person with stroke on a daily basis with the assistance of their family for a period of 8 weeks.

Study groups in NCT00666744
Study groupRoleWhat they receive
1ExperimentalExercise Intervention - additional lower limb exercises will be completed by the person with stroke with the assistance of his/her family for 35 minutes daily for a period of 8 weeks.
Receives: Other: Family Mediated Exercise Therapy
2No interventionParticipants in this group will receive routine exercise therapy following stroke

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fugl Meyer (FM) Assessment

    Measured: Baseline, post intervention and 3 month follow-up

Secondary outcomes (6)
  1. Berg Balance Scale (BBS)

    Measured: Baseline, post intervention and 3 month follow-up

  2. Motor Assessment Scale (MAS)

    Measured: Baseline, post-intervention and 3 month follow up

  3. Six Minute Walk Test (SMWT)

    Measured: Baseline, post-intervention and 3 month follow up

  4. Barthel Index (BI)

    Measured: Baseline, post-intervention and 3 month follow up

  5. Re-integration into Normal Living Index (RNLI)

    Measured: Baseline, post-intervention and 3 month follow up

  6. Nottingham Extended Activities of Daily Living (EADL)

    Measured: Baseline, post-intervention and 3 month follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Apr 2008 (estimated)
  2. Study startApr 2008
  3. Primary completionMar 2009 (estimated)
  4. Study completionMar 2009 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Single group
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00666744
Sponsor's protocol ID
08/19
Other IDs
Irish Heart Foundation - FAME
Acronym
FAME
Status last verified
Apr 2008
First submitted
23 Apr 2008
Last updated
29 Oct 2008
Results posted
No
Data monitoring committee
No

Publications

  • Galvin R, Cusack T, Stokes E. A randomised controlled trial evaluating family mediated exercise (FAME) therapy following stroke. BMC Neurol. 2008 Jun 20;8:22. doi: 10.1186/1471-2377-8-22.

    PubMed 18570643

Questions about this trial

What is this clinical trial studying?

A Phase 3 study testing Family Mediated Exercise Therapy in people with Weakness and Balance, run by University of Dublin, Trinity College at 2 sites in Ireland.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 29 Oct 2008. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Ireland. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Emma K Stokes, PhD (00 353 1 896 2127, estokes@tcd.ie), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fugl Meyer (FM) Assessment (time frame: Baseline, post intervention and 3 month follow-up). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00666744, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2008.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in